These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 20817473

  • 1. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
    Bindi S, Fancelli D, Alli C, Berta D, Bertrand JA, Cameron AD, Cappella P, Carpinelli P, Cervi G, Croci V, D'Anello M, Forte B, Giorgini ML, Marsiglio A, Moll J, Pesenti E, Pittalà V, Pulici M, Riccardi-Sirtori F, Roletto F, Soncini C, Storici P, Varasi M, Volpi D, Zugnoni P, Vianello P.
    Bioorg Med Chem; 2010 Oct 01; 18(19):7113-20. PubMed ID: 20817473
    [Abstract] [Full Text] [Related]

  • 2. 3-Amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: a new class of CDK2 inhibitors.
    Pevarello P, Fancelli D, Vulpetti A, Amici R, Villa M, Pittalà V, Vianello P, Cameron A, Ciomei M, Mercurio C, Bischoff JR, Roletto F, Varasi M, Brasca MG.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):1084-90. PubMed ID: 16290148
    [Abstract] [Full Text] [Related]

  • 3. 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.
    Fancelli D, Moll J, Varasi M, Bravo R, Artico R, Berta D, Bindi S, Cameron A, Candiani I, Cappella P, Carpinelli P, Croci W, Forte B, Giorgini ML, Klapwijk J, Marsiglio A, Pesenti E, Rocchetti M, Roletto F, Severino D, Soncini C, Storici P, Tonani R, Zugnoni P, Vianello P.
    J Med Chem; 2006 Nov 30; 49(24):7247-51. PubMed ID: 17125279
    [Abstract] [Full Text] [Related]

  • 4. Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinase.
    Prime ME, Courtney SM, Brookfield FA, Marston RW, Walker V, Warne J, Boyd AE, Kairies NA, von der Saal W, Limberg A, Georges G, Engh RA, Goller B, Rueger P, Rueth M.
    J Med Chem; 2011 Jan 13; 54(1):312-9. PubMed ID: 21128645
    [Abstract] [Full Text] [Related]

  • 5. PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity.
    Soncini C, Carpinelli P, Gianellini L, Fancelli D, Vianello P, Rusconi L, Storici P, Zugnoni P, Pesenti E, Croci V, Ceruti R, Giorgini ML, Cappella P, Ballinari D, Sola F, Varasi M, Bravo R, Moll J.
    Clin Cancer Res; 2006 Jul 01; 12(13):4080-9. PubMed ID: 16818708
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
    Zheng LW, Zhu J, Zhao BX, Huang YH, Ding J, Miao JY.
    Eur J Med Chem; 2010 Dec 01; 45(12):5792-9. PubMed ID: 20947221
    [Abstract] [Full Text] [Related]

  • 7. The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: a new class of Aurora-A kinase inhibitors.
    Moriarty KJ, Koblish HK, Garrabrant T, Maisuria J, Khalil E, Ali F, Petrounia IP, Crysler CS, Maroney AC, Johnson DL, Galemmo RA.
    Bioorg Med Chem Lett; 2006 Nov 15; 16(22):5778-83. PubMed ID: 16949284
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovery and structural optimization of pyrazole derivatives as novel inhibitors of Cdc25B.
    Chen HJ, Liu Y, Wang LN, Shen Q, Li J, Nan FJ.
    Bioorg Med Chem Lett; 2010 May 01; 20(9):2876-9. PubMed ID: 20363629
    [Abstract] [Full Text] [Related]

  • 11. Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
    Price S, Bordogna W, Bull RJ, Clark DE, Crackett PH, Dyke HJ, Gill M, Harris NV, Gorski J, Lloyd J, Lockey PM, Mullett J, Roach AG, Roussel F, White AB.
    Bioorg Med Chem Lett; 2007 Jan 15; 17(2):370-5. PubMed ID: 17095213
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
    Zhang L, Fan J, Chong JH, Cesena A, Tam BY, Gilson C, Boykin C, Wang D, Aivazian D, Marcotte D, Xiao G, Le Brazidec JY, Piao J, Lundgren K, Hong K, Vu K, Nguyen K, Gan LS, Silvian L, Ling L, Teng M, Reff M, Takeda N, Timple N, Wang Q, Morena R, Khan S, Zhao S, Li T, Lee WC, Taveras AG, Chao J.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5633-7. PubMed ID: 21798738
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF, Lu X, Zhang Y, Song GQ, He QL, Li QS, Yang XH, Wei Y, Zhu HL.
    Bioorg Med Chem; 2012 Aug 15; 20(16):4895-900. PubMed ID: 22819191
    [Abstract] [Full Text] [Related]

  • 14. NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor.
    Beria I, Bossi RT, Brasca MG, Caruso M, Ceccarelli W, Fachin G, Fasolini M, Forte B, Fiorentini F, Pesenti E, Pezzetta D, Posteri H, Scolaro A, Re Depaolini S, Valsasina B.
    Bioorg Med Chem Lett; 2011 May 15; 21(10):2969-74. PubMed ID: 21470862
    [Abstract] [Full Text] [Related]

  • 15. Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile.
    Chiang CC, Lin YH, Lin SF, Lai CL, Liu C, Wei WY, Yang SC, Wang RW, Teng LW, Chuang SH, Chang JM, Yuan TT, Lee YS, Chen P, Chi WK, Yang JY, Huang HJ, Liao CB, Huang JJ.
    J Med Chem; 2010 Aug 26; 53(16):5929-41. PubMed ID: 20681538
    [Abstract] [Full Text] [Related]

  • 16. Novel cyano- and N-isopropylamidino-substituted derivatives of benzo[b]thiophene-2-carboxanilides and benzo[b]thieno[2,3-c]quinolones: synthesis, photochemical synthesis, crystal structure determination, and antitumor evaluation. 2.
    Jarak I, Kralj M, Suman L, Pavlović G, Dogan J, Piantanida I, Zinić M, Pavelić K, Karminski-Zamola G.
    J Med Chem; 2005 Apr 07; 48(7):2346-60. PubMed ID: 15801828
    [Abstract] [Full Text] [Related]

  • 17. SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
    Arbitrario JP, Belmont BJ, Evanchik MJ, Flanagan WM, Fucini RV, Hansen SK, Harris SO, Hashash A, Hoch U, Hogan JN, Howlett AR, Jacobs JW, Lam JW, Ritchie SC, Romanowski MJ, Silverman JA, Stockett DE, Teague JN, Zimmerman KM, Taverna P.
    Cancer Chemother Pharmacol; 2010 Mar 07; 65(4):707-17. PubMed ID: 19649632
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives.
    Zhang D, Wang G, Zhao G, Xu W, Huo L.
    Eur J Med Chem; 2011 Dec 07; 46(12):5868-77. PubMed ID: 22000925
    [Abstract] [Full Text] [Related]

  • 19. Microwave-assisted synthesis, crystal structure of pyrazolo[1,5-a]pyrazin-4(5H)-ones and their selective effects on lung cancer cells.
    Liu N, Zhang JH, Zhao BX, Zhao J, Su L, Dong WL, Zhang SL, Miao JY.
    Eur J Med Chem; 2011 Jun 07; 46(6):2359-67. PubMed ID: 21463913
    [Abstract] [Full Text] [Related]

  • 20. The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents.
    Laufer R, Forrest B, Li SW, Liu Y, Sampson P, Edwards L, Lang Y, Awrey DE, Mao G, Plotnikova O, Leung G, Hodgson R, Beletskaya I, Mason JM, Luo X, Wei X, Yao Y, Feher M, Ban F, Kiarash R, Green E, Mak TW, Pan G, Pauls HW.
    J Med Chem; 2013 Aug 08; 56(15):6069-87. PubMed ID: 23829549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.